{"name":"Mark Stein","slug":"mark-stein","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxNU3NhVWdSTHM1U3NHSkxwMnNoYmVXNVlES2pBUng2M0dnMzdWRmdIdGd0em1NN1p6LW15MFlheXdzSE5RemZGUFg3d0FVcG02dUtvSUhNZFFuamx0WXhCWllFR004S1FZUFZLWW1qYkRWSnFsbTdkVTNHNTBBeVBnSDhJWlFvV2RoalhGYUxPcllaeF9GbkV5dmplajhqandpOHRLaTJwb3E1V2tUYlJnYmRUeEsxRWdMRFdZS1dIeVZKbTFhdVdOaFgwdG5kOURnbmdja0NNU0dCWnYzNi1sclhzWHUtdGhhamZCUXl4VjdoeXNS?oc=5","date":"2026-03-22","type":"pipeline","source":"BioPharma APAC","summary":"GI Innovation Enters Clinical Supply Agreement With Johnson And Johnson To Advance Prostate Cancer Combination Therapy - BioPharma APAC","headline":"GI Innovation Enters Clinical Supply Agreement With Johnson And Johnson To Advance Prostate Cancer Combination Therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiS0FVX3lxTFBRYkVZekw0VFN4OXVwaVhGaFdRRWRsRExNU2hHTFlvNmNzT3hwYTBXU2F2T1YzT1pLNHl3dFNuMkZCWGVCcFpER3ZEcw?oc=5","date":"2026-03-20","type":"pipeline","source":"매일경제","summary":"GI Innovation is working with Johnson & Johnson (J&J), a global pharmaceutical company, to d.. - 매일경제","headline":"GI Innovation is working with Johnson & Johnson (J&J), a global pharmaceutical company, to d.. - 매일경제","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTFBIVkl3QTBQbjA3cUxjd0ZSQkNPeWF1M29Zcld5TF96UUhfdF8wTGU4UDg1ZTdnbDlwR2lsQ3IwNE9Jb25idk1vT1E2NzEyZWp4R3ZZdg?oc=5","date":"2026-02-09","type":"pipeline","source":"University of the Punjab","summary":"PU’s Oriental College pays tribute to Sir Mark Aurel Stein - University of the Punjab","headline":"PU’s Oriental College pays tribute to Sir Mark Aurel Stein","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQeU5nT25YZUFFWEdxb2l0X3REOElVUDZoU1NCWXFuWDlDQnpqYWVpYTRGdUljZXY2UzlXRHVxN05NV0ROSF92U21Bc1FtbUVWNWwzd1VfbklhaXJuN2tWeU5TVmhnYmkxOTQ1b0lwQTRRZi1PbUhreFBFbVZMNFk5Tw?oc=5","date":"2026-01-15","type":"pipeline","source":"Griffith University","summary":"Potential new treatment for sepsis - Griffith University","headline":"Potential new treatment for sepsis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQLVp6b0tabDhuNWtBRzB4V29HZXowQzl0blZaOS1KTXVaQUF3ZTFzYmhvZ2tEV0pUeEJFNzE4WjRidUVmcUFGRmsycGJBVm1XX2NNYUhVTTU1OW1wb3J6cnBacTR4UHZwdWFSUEFmQ1I0cHpFblZFRmdxMHNMdDhyQ3dZZUJJTzA2dU13YmpBMDQyVGpyS1E?oc=5","date":"2025-04-11","type":"pipeline","source":"WUNC News","summary":"Stein marks first 100 days with wins — so far. Tough tests are coming - WUNC News","headline":"Stein marks first 100 days with wins — so far. Tough tests are coming","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTFAxMTQ3a0JEZDdwY1hRTk5QWUJDYm0weWlEUEtUZjdQVVotSjAtRUxsQW4xelNSZlRYbm8xU2V1SHBrbUFiWEJxMTh2MF81cWhqbURuZEwzRU5kc3dVRnVQYm5RQlZpRWpYRnNrT1U3QXgwQkkxaGU3YjlENGN2LVE?oc=5","date":"2025-04-02","type":"regulatory","source":"Pharma Voice","summary":"Is the FDA ‘finished’? Leadership drain hits agency hard. - Pharma Voice","headline":"Is the FDA ‘finished’? Leadership drain hits agency hard.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNcC1jenhNVXMtWHRneWZYemRsdUo5c0dBM1J5R2o0eHhvWWFmQUhEakM3Q1Q0RFlsZEVqWEZBUXdfdjY1MGZKb1NfUXNqeVFfaWFYYUt5c0t2U1QxYmJyc0VOeUdzVUNBUmR4bXJfQWJBQ211eXlacDZlMnQ3WERZWVhDdnNORjJJTkxwU3VwRkw?oc=5","date":"2025-04-01","type":"regulatory","source":"Barron's","summary":"FDA Is ‘Finished’ Amid HHS Firings. Drug Stocks are Dropping - Barron's","headline":"FDA Is ‘Finished’ Amid HHS Firings. Drug Stocks are Dropping - Barron's","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1rRnQ1LXRZcGYtR0xBZlRTLVRCVWlzMWJfenB5bHNBRGFRa01Qa245dVA0aFVqNFlTRHU2M25vX09hdjJieXZnSTJ4aUJDTlhSakI1cWFWYTF5SVJqTWp3?oc=5","date":"2024-12-30","type":"trial","source":"nature.com","summary":"PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial - nature.com","headline":"PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate can","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPZjlvSVVhS0lTaXN2bmducUEyei10YmlNd181UWZ1M2RKczFZZXdiQVBjc3oxRjBuZWpnSUliY3JfblpQMDROMzY4RGVzbWpWdmtRb2YzeXNJTmVwVkFpaU92dkJET01mWjItNmszend1SDZiWmhGZXpEMW1ac3Q2M1dBRUtkWEZDNVJjdzZIRy1MVDRfZlFILWJzUHJRZkZRaE1SZVBzaGNpOGxSck1r?oc=5","date":"2023-06-15","type":"deal","source":"morganlewis.com","summary":"Morgan Lewis Represents Blue Rabbit in Merger with Wedgewood Pharmacy – News - morganlewis.com","headline":"Morgan Lewis Represents Blue Rabbit in Merger with Wedgewood Pharmacy – News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9pdlVBc0lUWkJKc2tybUg2Z1NISXd1VWFhdTdVSlJ5ZHBtRU9iVzFxejlhSmNTNzVuWnU5UFdxcGk0M0NZbXpkX3hTTEhySF9yMmZxN3FnQ0doek1IRHNTTUppeUdtWnJFVmJ5eE9Ydm9wN3liRXpCN0dnUGo?oc=5","date":"2021-05-18","type":"pipeline","source":"Binghamton University","summary":"PwC Scholars complete two community service projects - Binghamton University","headline":"PwC Scholars complete two community service projects","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxQS0xRRUpRMW5FaXZ4NFpkamtSUnpoY0FTMnBEbVU5ZE9QaDlxenFMX2FDbXBXdElrN1RyUEdYcUFHOGlVN0RKbDV0QS1lbi1UWEh0RnhWaVNQa0hJZHVRODNhb29lczhvbU9ycDcwU1QyVXVYSFVZOTBIQjdIanZzVXc5NWhxajNQMVgzLXVfUVpVVmgzNktsNUVpOU95YUVDZlBGTU5zeWJpcng4bVdlOUd2aDZxdjhfYXRyVlhPZkQyZ3pqdkhUZTQ5RmVtUWs?oc=5","date":"2019-05-22","type":"pipeline","source":"News-Medical","summary":"Expanding scope of stimulants to better treat attention deficit hyperactivity disorder - News-Medical","headline":"Expanding scope of stimulants to better treat attention deficit hyperactivity disorder - News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTFA5RmNTdTJGcmVwNEYyeDl5MFJZWHk4dGd1ZlN6QWpEa1BkYjVrX045cU9xVmpNZmlBWG1vMVFKa1k2TlZMS05lZmstczg5emRaamlubzU2YUF0TWl6bG9uMG9COTN1LW8?oc=5","date":"2008-07-22","type":"pipeline","source":"The New York Times","summary":"Filling in a Few Blanks in an Old Brooklyn Real Estate Mystery (Published 2008) - The New York Times","headline":"Filling in a Few Blanks in an Old Brooklyn Real Estate Mystery (Published 2008)","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}